Company intelligence / Profile preview

Dow Jones Newswires

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Dow Jones Newswires is a leading global provider of real-time financial news, data, and analysis. As a division of Dow Jones & Company, it delivers market-moving information and actionable insights to financial professionals, corporate executives, and investors. While the organization provides extensive coverage of the life sciences, biotechnology, and pharmaceutical sectors, it operates as a news and information agency rather than a healthcare or drug development company. Its services include real-time reporting on clinical trial results, regulatory decisions, and corporate mergers and acquisitions within the global healthcare industry.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Dow Jones Newswires.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dow Jones Newswires.

Explore the full profile